AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.555
-0.125 (-3.40%)
At close: 4:00PM EST

3.560 0.00 (0.14%)
After hours: 4:21PM EST

Stock chart is not supported by your current browser
Previous Close3.680
Open3.640
Bid3.400 x 4000
Ask3.560 x 4000
Day's Range3.320 - 3.660
52 Week Range3.110 - 9.290
Volume1,653,540
Avg. Volume1,261,927
Market Cap255.642M
Beta (3Y Monthly)-1.17
PE Ratio (TTM)N/A
EPS (TTM)-3.028
Earnings DateNov 12, 2018 - Nov 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.50
Trade prices are not sourced from all markets
  • Here's Why Amyris Can't Stop Sliding This Week
    Motley Fool4 days ago

    Here's Why Amyris Can't Stop Sliding This Week

    The company published SEC filings that go into more detail than its recent press release -- and investors don't like what they see.

  • Here's Why Amyris Is Getting Obliterated Today
    Motley Fool6 days ago

    Here's Why Amyris Is Getting Obliterated Today

    The synthetic biology pioneer reported third-quarter 2018 operating results.

  • Thomson Reuters StreetEvents7 days ago

    Edited Transcript of AMRS earnings conference call or presentation 13-Nov-18 9:30pm GMT

    Q3 2018 Amyris Inc Earnings Call

  • GlobeNewswire7 days ago

    Amyris Reports Third Quarter 2018 Financial Results

    Q3 2018 GAAP revenue of $14.9 million, compared with GAAP revenue of $24.2 million for Q3 2017. Third-quarter revenue of $14.9 million compared with the same period in 2017 of.

  • Benzinga7 days ago

    Amyris Q3 Earnings Outlook

    Amyris, Inc. (NASDAQ: AMRS ) announces its next round of earnings this Tuesday, Nov. 13. Here's Benzinga's advanced look at Amyris' Q3 earnings report. Earnings and Revenue Based on Amyris management projections, ...

  • Simply Wall St.12 days ago

    Amyris Inc (NASDAQ:AMRS): Is Breakeven Near?

    Amyris Inc’s (NASDAQ:AMRS): Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The US$472m market-cap posted a loss in its most recent financial year of -US$93m and Read More...

  • GlobeNewswire12 days ago

    Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd.

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has already expanded its original collaboration with Yifan Pharmaceutical Co., Ltd. (SZ.002019) (“Yifan”) from its September 2018 agreement. Yifan will add a second molecule from Amyris to its vitamin portfolio. This new multi-million-dollar collaboration between Amyris and Yifan deepens the partnership between the two companies, with immediate revenue from developing products and expected product commercialization as early as 2021, as well as plans for additional products in the future.

  • Amyris (AMRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks14 days ago

    Amyris (AMRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Amyris (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire21 days ago

    Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018

    EMERYVILLE, Calif., Oct. 30, 2018 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2018 after market close on Tuesday,.

  • GlobeNewswire28 days ago

    Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development

    EMERYVILLE, Calif. and MADRID, Spain, Oct. 23, 2018 -- At the prestigious CPhI Pharma Awards Gala held October 9, in Madrid, Ipca Laboratories, Ltd. was awarded the 2018 CPhI.

  • GlobeNewswirelast month

    Amyris Successfully Producing its New Zero Calorie Natural Sweetener at Industrial Scale

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, is pleased to announce that industrial scale production of what it believes is the world’s best tasting and lowest cost zero calorie natural sweetener has started and is successfully operating as expected. Amyris recently signed its first major supply and distribution agreement for its sweetener with ASR Group, the world’s largest cane sugar refiner and expects other agreements to follow very soon. “Our team has done an incredible job successfully scaling our technology to produce what we believe to be the world’s leading natural sweetener,” said Amyris President & CEO John Melo.

  • Better Synthetic Biology Stock: Amyris vs. Codexis
    Motley Foollast month

    Better Synthetic Biology Stock: Amyris vs. Codexis

    Both stocks have gained over 140% in the last year alone. Both are looking forward to growth from innovative sweetener ingredients. One doesn't belong in your portfolio.

  • GlobeNewswire2 months ago

    Amyris Signs First Major Supply and Distribution Agreement for its New, Zero Calorie Sweetener with ASR Group, the World’s Largest Cane Sugar Refiner

    Amyris, Inc. (AMRS) a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets today announced it has signed its first major supply and distribution agreement for its new, sugarcane-derived, zero calorie sweetener with ASR Group, the world’s largest cane sugar refiner. “We are pleased to collaborate with Amyris to deliver a great-tasting, zero calorie sweetener made from cane sugar to the marketplace.  This product is among the highest in purity and best in flavor profile that we have seen,” said Richard Dyer, Chief Science and Innovation Officer for ASR Group.

  • GlobeNewswire2 months ago

    Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has entered into a multi-year, multi-million-dollar agreement with a subsidiary of Yifan Pharmaceutical Co., Ltd. (SZ.002019)(“Yifan”). Yifan is one of the leading Chinese pharmaceutical companies focusing on innovation, R&D, and manufacturing with a strong market position and focus on active pharmaceutical ingredients (APIs) including nutritional products, biologics, high-end small molecule drugs, and special traditional Chinese medicine. This collaboration is anticipated to be the start of a long-term relationship with Yifan starting with the first target in nutrition for a key molecule to be developed, scaled and manufactured by Amyris.

  • GlobeNewswire2 months ago

    Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 4, 2018

    Amyris will provide an update on its business and new market opportunities and initiatives during the presentation, which is scheduled for Thursday, October 4, at 10:00 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.

  • GlobeNewswire2 months ago

    Amyris Provides Update on Leland, NC Production Facility

    Assessments continue, but Amyris expects a quick return to full production once power is restored and the plant is back online. Amyris expects to resume full production of its squalane product for customers without any impact to its third quarter or full year squalane results. Customers including 2,000 of the world’s leading skin care brands as well as Amyris’s own Biossance brand will receive their needed supplies without interruption or any price change.

  • GlobeNewswire2 months ago

    Amyris to Host Launch of its New Zero Calorie Natural Sweetener in New York on December 3, 2018

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced today that it plans to hold an invitation only, special tasting event to mark the official commercial launch of its new, sugarcane-derived, natural, zero calorie sweetener on December 3, 2018 in New York. Guests will be among the first to experience what the company believes is the best tasting, zero calorie natural sweetener commercially available in the world today. “Amyris started out developing and making sustainable the leading antimalarial treatment.

  • TheStreet.com3 months ago

    Salesforce Remains a 'Go to' Name for Big Cap Momentum Players

    Strong markets tend to stay sticky to the upside and that is what we are seeing this morning despite overbought conditions in a thin market. There is some optimism about a trade deal with Canada but no major news events are driving the action right now.

  • GlobeNewswire3 months ago

    Amyris to Present at Rodman & Renshaw 20th Annual Global Investment Conference on September 5, 2018

    Amyris will provide an update on its business during the presentation, which is scheduled for Wednesday, September 5, at 9:10 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.

  • GlobeNewswire3 months ago

    Amyris Gets Green Light for Commercial Sales of its New, Natural, Zero-Calorie Sweetener

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced today that its zero-calorie sweetener made from sugarcane has received designation as GRAS (Generally Recognized as Safe) by an independent expert panel. This designation is based on FDA requirements and allows Amyris to begin commercially selling its new, natural, zero-calorie sweetener. “We’ve known for a while that our plant-based, zero-calorie sweetener tastes really great – our testers have said it tastes just like sugar and that’s because it’s made naturally from sugarcane.

  • This Synthetic Biology Stock Is Soaring, but Investors Shouldn't Overlook a Key Risk
    Motley Fool3 months ago

    This Synthetic Biology Stock Is Soaring, but Investors Shouldn't Overlook a Key Risk

    Is Amyris significantly overestimating the royalty revenue it's owed? If so, that could really hurt shareholders down the road.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of AMRS earnings conference call or presentation 6-Aug-18 8:30pm GMT

    Q2 2018 Amyris Inc Earnings Call

  • Here's Why Amyris Fell More Than 13% Today
    Motley Fool3 months ago

    Here's Why Amyris Fell More Than 13% Today

    The synthetic biology pioneer announced a secondary share offering and the exercise of warrants.